Advocacy in Action: November 2024
Welcome to ASRM's Advocacy in Action, where we give an overview of what our Government Affairs team has been working on, summarize relevant federal and state legislation, and highlight the advocacy and outreach efforts of our members. We are so thankful for the advocacy of our members; please get in touch with the Office of Public Affairs at
[email protected] for more information on ways to get involved.
-
Applications to the CPL's PRIMED program are open through December 2! Are you a reproductive medicine expert looking to get more involved in the world of advocacy? Apply for the second cohort of the one-of-a-kind training program here.
-
On November 12, the Office of Public Affairs held a briefing on newly expanded fertility benefits for members of Congress and Congressional staff via FEHB and DC Exchange. Learn about the significance of the expanded benefits here.
-
ASRM members Dr. Albert Hsu, Dr. Ginny Ryan, Dr. Paula Amato, and Dr. Rachel Whynott attended the American Medical Association's interim House of Delegates meeting, where they successfully presented a resolution on behalf of ASRM expanding the definition of infertility coverage to include gender identity and sexuality.
-
Thank you to the awesome advocates who stopped by the Public Affairs booth at ASRM 2024! With your help, we conducted outreach to undecided voters in states where reproductive rights were on the ballot, most notably sending 600 postcards to voters in Nebraska. Member advocacy makes all the difference!
-
ASRM is thrilled that ballot measures protecting reproductive rights PASSED in 7 of the 10 states where they appeared on the ballot!
-
ASRM's first Congressional scorecard is here! Click here to see where your representatives stand on legislation around IVF.
Are you interested in making a difference?
Fill out this form to share your information and interests for our advocacy efforts and stay involved as we work together to create a brighter future.
If you would like to support us in our fight against restrictive reproductive legislation,
please visit our Advocacy in Action Fund.